Earnings Preview For Moleculin Biotech
Portfolio Pulse from Benzinga Insights
Moleculin Biotech (NASDAQ:MBRX) is set to release its latest quarterly earnings report on Friday, 2023-08-11. Analysts estimate an EPS of $-0.28. The company's past performance shows a trend of missing EPS estimates and subsequent share price drops. The stock is currently trading at $0.6, down 62.96% over the last 52-week period.
August 10, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Moleculin Biotech is expected to report an EPS of $-0.28 in its upcoming earnings report. The company's history of missing EPS estimates and subsequent share price drops could potentially impact the stock negatively.
Moleculin Biotech has a history of missing EPS estimates, which has previously led to significant drops in its share price. Given this trend, it's likely that the upcoming earnings report could have a negative impact on the stock, especially if the company fails to meet the estimated EPS of $-0.28.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100